DK1206567T3 - In vivo höj-kapacitet toksikologisk screeningsfremgangsmåde - Google Patents
In vivo höj-kapacitet toksikologisk screeningsfremgangsmådeInfo
- Publication number
- DK1206567T3 DK1206567T3 DK00952321T DK00952321T DK1206567T3 DK 1206567 T3 DK1206567 T3 DK 1206567T3 DK 00952321 T DK00952321 T DK 00952321T DK 00952321 T DK00952321 T DK 00952321T DK 1206567 T3 DK1206567 T3 DK 1206567T3
- Authority
- DK
- Denmark
- Prior art keywords
- subject
- screening method
- capacity
- libraries
- high throughput
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14720099P | 1999-08-04 | 1999-08-04 | |
| US09/472,654 US6365129B1 (en) | 1999-08-04 | 1999-12-27 | Invivo high throughput toxicology screening method |
| PCT/US2000/020849 WO2001011076A1 (en) | 1999-08-04 | 2000-07-31 | In vivo high throughput toxicology screening method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1206567T3 true DK1206567T3 (da) | 2009-05-11 |
Family
ID=26844683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00952321T DK1206567T3 (da) | 1999-08-04 | 2000-07-31 | In vivo höj-kapacitet toksikologisk screeningsfremgangsmåde |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1206567B1 (da) |
| AT (1) | ATE420354T1 (da) |
| AU (1) | AU781138B2 (da) |
| CA (1) | CA2381144C (da) |
| DE (1) | DE60041337D1 (da) |
| DK (1) | DK1206567T3 (da) |
| ES (1) | ES2319959T3 (da) |
| WO (1) | WO2001011076A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7415358B2 (en) | 2001-05-22 | 2008-08-19 | Ocimum Biosolutions, Inc. | Molecular toxicology modeling |
| US7447594B2 (en) | 2001-07-10 | 2008-11-04 | Ocimum Biosolutions, Inc. | Molecular cardiotoxicology modeling |
| US7469185B2 (en) | 2002-02-04 | 2008-12-23 | Ocimum Biosolutions, Inc. | Primary rat hepatocyte toxicity modeling |
| WO2005069872A2 (en) * | 2004-01-15 | 2005-08-04 | Washington University | High throughput pharmaceutical screening using drosophila |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254799A (en) * | 1985-01-18 | 1993-10-19 | Plant Genetic Systems N.V. | Transformation vectors allowing expression of Bacillus thuringiensis endotoxins in plants |
| US5180838A (en) * | 1986-08-26 | 1993-01-19 | Her Majesty The Queen As Represented By The Minister Of National Defense Of Her Majesty's Canadian Government | Phototoxic compounds for use as insect control agents |
| DE3715114A1 (de) * | 1987-05-06 | 1988-11-17 | Krause Hans | Verfahren und einrichtung zum toxizitaetsnachweis in oberflaechengewaessern sowie in trink- und brauchwasser |
| US5204100A (en) * | 1991-02-01 | 1993-04-20 | Ciba-Geigy Corporation | Baciullus thuringiensis strains active against coleopteran insects |
| UA48104C2 (uk) * | 1991-10-04 | 2002-08-15 | Новартіс Аг | Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника |
| IL104419A0 (en) * | 1992-01-24 | 1993-05-13 | Fmc Corp | Insecticidally effective peptides |
| CA2111521A1 (en) * | 1993-12-15 | 1995-06-16 | Stroud Water Research Center, Inc. | Mayfly centroptilum triangulifer as a bioassay organism |
| US6063756A (en) * | 1996-09-24 | 2000-05-16 | Monsanto Company | Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor |
| US6548733B2 (en) * | 1998-12-21 | 2003-04-15 | The Genetics Company, Inc. | Function-based small molecular weight compound screening system in drosophila melanogaster |
-
2000
- 2000-07-31 ES ES00952321T patent/ES2319959T3/es not_active Expired - Lifetime
- 2000-07-31 CA CA2381144A patent/CA2381144C/en not_active Expired - Fee Related
- 2000-07-31 WO PCT/US2000/020849 patent/WO2001011076A1/en active IP Right Grant
- 2000-07-31 AT AT00952321T patent/ATE420354T1/de not_active IP Right Cessation
- 2000-07-31 AU AU65043/00A patent/AU781138B2/en not_active Ceased
- 2000-07-31 DK DK00952321T patent/DK1206567T3/da active
- 2000-07-31 DE DE60041337T patent/DE60041337D1/de not_active Expired - Lifetime
- 2000-07-31 EP EP00952321A patent/EP1206567B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2381144A1 (en) | 2001-02-15 |
| CA2381144C (en) | 2012-05-01 |
| EP1206567A1 (en) | 2002-05-22 |
| EP1206567B1 (en) | 2009-01-07 |
| ES2319959T3 (es) | 2009-05-18 |
| ATE420354T1 (de) | 2009-01-15 |
| WO2001011076A1 (en) | 2001-02-15 |
| AU6504300A (en) | 2001-03-05 |
| EP1206567A4 (en) | 2005-11-23 |
| DE60041337D1 (de) | 2009-02-26 |
| AU781138B2 (en) | 2005-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Latypov et al. | Assignment of the absolute configuration of β-chiral primary alcohols by NMR: scope and limitations | |
| WO2003029264A3 (en) | 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof | |
| DE60040677D1 (de) | Verbessertes toxizität-screening verfahren | |
| ATE234268T1 (de) | Synthese von n-substituierten oligomeren | |
| ATE395041T1 (de) | Zusammensetzungen enthaltend mindestens ein polyamid, mindestens einen inerten füller und wachs | |
| Payne et al. | Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 3. Proliferation and differentiation of encapsulated marrow stromal osteoblasts cultured on crosslinking poly (propylene fumarate) | |
| WO1999065712A3 (en) | Glycosulfopeptides and methods of synthesis and use thereof | |
| CY1114303T1 (el) | Νεο οξινο θειικο αλας | |
| WO2007012695A3 (en) | Tissue carbohydrate compositions and analysis thereof | |
| Hixon et al. | Nitrogen isotope (δ15N) patterns for amino acids in lemur bones are inconsistent with aridity driving megafaunal extinction in south‐western Madagascar | |
| DK1206567T3 (da) | In vivo höj-kapacitet toksikologisk screeningsfremgangsmåde | |
| DK1077218T3 (da) | Peptidomimetiske forbindelser omfattende RGD-sekvenser, som er nyttige som integrininhibitorer | |
| DE112007000484B4 (de) | Stabil isotopenmarkierte aliphatische Aminosäuren, Verfahren zum Einbringen von diesen in ein Zielprotein und Verfahren zur NMR-Konformationsanalyse von Proteinen | |
| Narasimhan et al. | QSAR studies of antibacterial ricinoleic acid derivatives | |
| WO2000006525A3 (en) | Synthesis of combinatorial libraries of compounds reminiscent of natural products | |
| EP1146030A3 (en) | Combinatorial synthesis and analysis of organometallic compounds and catalysts | |
| Joergensen et al. | The electronic structure of. beta.-thioxoketones. A photoelectron spectroscopic study of the enol-enethiol tautomerism of thioacetylacetone and related compounds | |
| FR2852959B1 (fr) | Nouveaux derives de cyclodextrines, leur procede de preparation et leur utilisation notamment pour solubilisation de substances pharmacologiquement actives | |
| ATE494371T1 (de) | Nukleinsäureleitern | |
| Kuo et al. | Biosynthesis of the pipecolate moiety of marcfortine A | |
| DE60023544D1 (de) | Zusammensetzungen enthaltend eine kombination von defi und modifizierten defi und verfahren zur herstellung | |
| EA200800003A1 (ru) | Фунгицидные комбинации биологически активных веществ | |
| ATE306559T1 (de) | Verfahren zum screenen von verbindungen mit bioaktivität in organgeweben | |
| Joergensen et al. | Search for a trans-disulfide: structural analysis of di-tert-adamantyl disulfide by photoelectron spectroscopy, derivation of. sigma. I (t-Ad), and molecular mechanics calculations for related bulky disulfides | |
| DE69421531D1 (de) | Verwendung von rosmanolderivaten zur herstellung von antiradikalischen und/oder antilipoperoxidativen und/oder hepatotropen arzneistoffen |